UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

Molecular cancer therapeutics, 2019-03, Vol.18 (3), p.531-540

2019

Volltextzugriff (PDF)

A Holistic Way to Understand the Determinants of Physical Activity in Urban New South Wales, Australia: A Codesigned Systems Mapping Project

Journal of physical activity & health, 2024-09, p.1-5

2024

Volltextzugriff (PDF)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers

Clinical and translational science, 2021-07, Vol.14 (4), p.1524-1534

2021

Volltextzugriff (PDF)

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

Journal of clinical oncology, 2001-09, Vol.19 (18), p.3852-3860

2001

Volltextzugriff (PDF)

Heart Foundation and Coastrek partnership: Hiking for healthy hearts

Heart, lung & circulation, 2022-12, Vol.31 (12), p.1710-1710

2022

Volltextzugriff (PDF)

Jump Rope for Heart turns 40

Heart, lung & circulation, 2022-05, Vol.31 (5), p.753-753

2022

Volltextzugriff (PDF)

Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3584-3584

2024

Volltextzugriff (PDF)

Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.114-114

2024

Volltextzugriff (PDF)

Time for social prescribing to Heart Foundation Walking

Heart, lung & circulation, 2022-06, Vol.31 (6), p.903-903

2022

Volltextzugriff (PDF)

Walking Our Way to a Healthier Australia

Heart, lung & circulation, 2024-01, Vol.33 (1), p.144-144

2024

Volltextzugriff (PDF)

Current status of multi‐disciplinary paediatric weight management services in Australia

Journal of paediatrics and child health, 2021-08, Vol.57 (8), p.1259-1266

2021

Volltextzugriff (PDF)

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up

Gynecologic oncology, 2019-06, Vol.153 (3), p.521-529

2019

Volltextzugriff (PDF)

First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and/or enzalutamide (ENZ) and chemotherapy (CT)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5031-5031

2021

Volltextzugriff (PDF)

BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS3167-TPS3167

2023

Volltextzugriff (PDF)

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

Journal of pediatric hematology/oncology, 2002-02, Vol.24 (2), p.101-105

2002

Volltextzugriff (PDF)

La enseñanza de la química. Tercera parte. Evaluación de los conocimientos de química desde secundaria hasta licenciatura

Educación química, 2018-08, Vol.15 (2), p.108

2018

Volltextzugriff (PDF)

Therapeutic Targeting of Transcription in Acute Promyelocytic Leukemia by Use of an Inhibitor of Histone Deacetylase

JNCI : Journal of the National Cancer Institute, 1998-11, Vol.90 (21), p.1621-1625

1998

Volltextzugriff (PDF)

Abstract LB315: Inhibition of FGFR4 with futibatinib combined with inhibition of IGF1R, Src family kinases, or AKT is synergistic against rhabdomyosarcoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB315-LB315

2023

Volltextzugriff (PDF)

Abstract 2498: The MVA viral platform for the treatment of cancer and chronic infectious diseases: Clinical experience from four randomized controlled phase II studies

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2498-2498

2015

Volltextzugriff (PDF)

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

The New England journal of medicine, 1998-11, Vol.339 (19), p.1341-1348

1998

Volltextzugriff (PDF)

The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up

Obstetrical & gynecological survey, 2019-09, Vol.74 (9), p.529-530

2019

Volltextzugriff (PDF)

Satisfaction and acceptability of paediatric weight management services amongst parents and carers: A mixed‐methods study

Clinical obesity, 2020-12, Vol.10 (6), p.n/a

2020

Volltextzugriff (PDF)

Enseñanza experimental en el bachillerato en el contexto de la Química Verde

Educación química, 2018-08, Vol.14 (3), p.142

2018

Volltextzugriff (PDF)

Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma

Clinical cancer research, 2001-10, Vol.7 (10), p.3065-3070

2001

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors

A Holistic Way to Understand the Determinants of Physical Activity in Urban New South Wales, Australia: A Codesigned Systems Mapping Project

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma

Heart Foundation and Coastrek partnership: Hiking for healthy hearts

Jump Rope for Heart turns 40

Impact of colorectal liver metastases (CRLM) in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Relationship between fluoropyrimidine (FPD) exposure and outcomes in patients with metastatic colorectal cancer (mCRC) receiving trifluridine/tipiracil (FTD/TPI) with or without bevacizumab (BEV) in the phase 3 SUNLIGHT trial

Time for social prescribing to Heart Foundation Walking

Walking Our Way to a Healthier Australia

Current status of multi‐disciplinary paediatric weight management services in Australia

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up

First-in-human study of TAS3681, an oral androgen receptor (AR) antagonist with AR and AR splice variant (AR-SV) downregulation activity, in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) refractory to abiraterone (ABI) and/or enzalutamide (ENZ) and chemotherapy (CT)

BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592)

Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience

La enseñanza de la química. Tercera parte. Evaluación de los conocimientos de química desde secundaria hasta licenciatura

Therapeutic Targeting of Transcription in Acute Promyelocytic Leukemia by Use of an Inhibitor of Histone Deacetylase

Abstract LB315: Inhibition of FGFR4 with futibatinib combined with inhibition of IGF1R, Src family kinases, or AKT is synergistic against rhabdomyosarcoma

Abstract 2498: The MVA viral platform for the treatment of cancer and chronic infectious diseases: Clinical experience from four randomized controlled phase II studies

Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide

The Efficacy and Safety of Tipapkinogen Sovacivec Therapeutic HPV Vaccine in Cervical Intraepithelial Neoplasia Grades 2 and 3: Randomized Controlled Phase II Trial with 2.5 Years of Follow-up

Satisfaction and acceptability of paediatric weight management services amongst parents and carers: A mixed‐methods study

Enseñanza experimental en el bachillerato en el contexto de la Química Verde

Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma

Suchergebnisse filtern